Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771
Published August 28, 2013 · Recall initiated: July 4, 2013
Summary
FDA records drug Class II recall D-913-2013, published August 28, 2013 and initiated July 4, 2013. Recalling firm: VistaPharm, Inc.; Status: Terminated; Reported quantity: 1,707,050 cups / 5ml ea.; Lot: Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- VistaPharm, Inc.
- Distributor
- Nationwide.
- Lot
- Lot # 240200, 243000, 244800, 245600, 250800 and 253600. Exp 06/13.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only,November 2, 2022
- FDAClobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FLJanuary 26, 2022
- FDANYSTATIN ORAL SUSPENSION, USP 100,000 units per mL Contains: Alcohol 0.5% v/v (Bubblegum Flavored) 16 fl. oz.October 14, 2020
- FDANystatin Oral Suspension, USP 500,000 units/5mL Cup, Delivers 5 mL, Rx Only, Manufactured by: VistaPharm,July 15, 2020
- FDAEyebright Concentrate Topical Eye Rinse, 1, 2, 4, 8, 16 & 32 fl oz bottles, Produced and distributed by: WiseAugust 28, 2013
- FDATagitol V Barium Sulfate Suspension (40% w/v, 30% w/w) Net Contents: 20 mL, (NDC 32909-814-53) Rx Only,August 28, 2013
Questions about this recall
Was Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo, FL 33771 recalled?
Yes. FDA published recall D-913-2013 on August 28, 2013. Reported hazard: Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit